Starpharma Holdings Limited
AU:
SPL
-
AUD
BIOTECHNOLOGY
A$1.28
-A$0.08
(-5.88%)
How to buy Starpharma Holdings (SPL) shares
Learn how to easily invest in Starpharma Holdings shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Starpharma Holdings Limited is a biotechnology business based in Australia. Starpharma Holdings shares (SPL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Starpharma Holdings has a trailing 12-month revenue of around $1.5 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Starpharma Holdings
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Starpharma Holdings . Find the share by name or ticker symbol: SPL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Starpharma Holdings reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Starpharma Holdings . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Starpharma Holdings stock price (ASX:SPL)
Use our graph to track the performance of SPL stocks over time.Starpharma Holdings shares at a glance
Information last updated 2021-07-24.
| 52-week range | $1.015 - $2.52 |
|---|---|
| 50-day moving average | $1.4827 |
| 200-day moving average | $1.7501 |
| Target price | $1.44 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.04 |
Share Trading Account Offer
IG Share Trading
AUD 8
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian shares, international shares, forex and CFD trading
- Monthly fee: $0.00
- Brokerage fee - standard trade: $8.00 or 0.1%
- International: Yes
- Support - After hours: Yes
More info
Important: Share trading carries risk of capital loss.
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Starpharma Holdings stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Starpharma Holdings price performance over time
Historical closes compared with the last close of A$1.675
| 1 month (2021-06-28) | 9.84% |
|---|---|
| 3 months (2021-04-28) | 0.30% |
Starpharma Holdings financials
| Revenue TTM | $1.5 million |
|---|---|
| Gross profit TTM | $5.7 million |
| Return on assets TTM | -20.52% |
| Return on equity TTM | -35.69% |
| Profit margin | 0% |
| Book value | 0.172 |
| Market capitalisation | $513.7 million |
TTM: trailing 12 months
Starpharma Holdings share dividends
We're not expecting Starpharma Holdings to pay a dividend over the next 12 months.
Starpharma Holdings share price volatility
Over the last 12 months, Starpharma Holdings 's shares have ranged in value from as little as $1.015 up to $2.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Starpharma Holdings 's is 1.2992. This would suggest that Starpharma Holdings 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Starpharma Holdings overview
Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Stocks similar to Starpharma Holdings
Starpharma Holdings in the news
Starpharma Holdings (ASX:SPL) Shareholders Have Enjoyed An Impressive 108% Share Price Gain
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to invest in the Clarity Pharmaceuticals IPO IPO
Everything we know about the Clarity Pharmaceuticals IPO IPO, plus information on how to buy in.
-
How to invest in the TEK-Ocean Group IPO
Everything we know about the TEK-Ocean Group IPO, plus information on how to buy in.
-
How to buy HNC Coin (HNC) in Australia
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
-
How to buy Maro (MARO) in Australia
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
-
How to buy Ethernity Chain (ERN) in Australia
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
-
How to buy Shopping.io (SPI) in Australia
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
-
How to buy LUKSO Token (LYXE) in Australia
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
-
How to buy KardiaChain (KAI) in Australia
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
-
How to buy Neutrino USD (USDN) in Australia
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
-
How to buy Venus BTC (VBTC) in Australia
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert
